T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.

@article{Garg2004T3DA,
  title={T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.},
  author={Amit K. Garg and Eric A Strom and Marsha D. McNeese and Aman U. Buzdar and Gabriel N Hortobagyi and Henry Mark Kuerer and George H. Perkins and Sonja E. Singletary and Kelly K. Hunt and Asyegul Sahin and Naomi R. Schechter and Vicente Valero and Susan L. Tucker and Thomas A. Buchholz},
  journal={International journal of radiation oncology, biology, physics},
  year={2004},
  volume={59 1},
  pages={138-45}
}
PURPOSE To help define the clinical and pathologic predictors of locoregional recurrence (LRR) in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy without radiotherapy for early-stage disease. METHODS AND MATERIALS We retrospectively reviewed the outcomes of all 132 patients with Stage I or II breast cancer treated in prospective institutional trials with neoadjuvant chemotherapy and mastectomy without radiotherapy between 1974 and 2001. The clinical stage (American… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…